<DOC>
	<DOC>NCT02269176</DOC>
	<brief_summary>Using Losartan as a comparator, to evaluate the efficacy and safety of telmisartan in the treatment of the mild to moderate primary hypertension patients in China</brief_summary>
	<brief_title>Efficacy and Safety of Telmisartan and Losartan in Primary Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Mild to moderate primary hypertension, the mean sitting valley value of diastolic blood pressure (DBP) â‰¥ 95 and &lt; 110 mmHg, and the mean sitting valley value of systolic blood pressure (SBP) &lt; 180 mmHg Not specified</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>